FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or its pharmaceutically acceptable salt comprising 5 wt.-%, not above, of its corresponding (+)-enantiomer. Also, invention relates to a composition used in treatment or prophylaxis of disorders relieved by inhibition of dopamine reuptake and containing the effective dose of (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or its pharmaceutically acceptable salt and comprising 5 wt.-%, not above, of its corresponding (+)-enantiomer and pharmaceutically an acceptable carrier of excipient. (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane or its pharmaceutically acceptable salt is used in producing a medicinal agent designated for treatment or prophylaxis of disorders relieved by inhibition of dopamine reuptake wherein these disorders are chosen from group consisting of disorder associated with attention deficiency, depression, obesity, Parkinson's disease, narcomania and tic. Also, invention relates to methods for synthesis of (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane. Invention provides synthesis and using (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or its pharmaceutically acceptable salt that are useful in treatment of prophylaxis of disorders relieved by inhibition of dopamine reuptake.
EFFECT: valuable medicinal properties of compound and composition.
19 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
(+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, COMPOSITIONS AND USING | 2002 |
|
RU2294926C2 |
AZABICYCLO{3,1,0}HEXANE DERIVATIVES USED AS DOPAMINE RECEPTOR D3 MODULATORS | 2005 |
|
RU2434011C2 |
TARTRATE SALTS OF 2-METHOXYMETHYL-3-(3,4-DICHLOROPHENYL)-8-AZABICYCLO[3,2,1]OCTANE | 2004 |
|
RU2348631C2 |
NEW DERIVATIVES OF PIPERIDINE AND THEIR USE AS INHIBITORS OF RECAPTURE OF NEUROMEDIATOR MONOAMINES | 2003 |
|
RU2325378C2 |
DERIVATIVES OF 8-AZABICYCLO[3,2,1]OCT-2-ENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DRUG PREPARING, METHODS OF INHIBITION OF REUPTAKE OF MONOAMINE NEUROMEDIATING AGENT, ESPECIALLY, SEROTONIN | 1996 |
|
RU2157372C2 |
3-AZABICYCLO[3,1,0]HEXYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | 2009 |
|
RU2510396C2 |
NEW 8-AZA-BICYCLO[3,2,1]OCTANE DERIVATIVES APPLIED AS MONOAMINE NEUROTRNSMITTER RECAPTURE INHIBITORS | 2004 |
|
RU2344136C2 |
AMINOCARBONYLCARBAMATE COMPOUNDS | 2015 |
|
RU2790360C2 |
TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS | 2007 |
|
RU2477634C2 |
AMINOCARBONYLCARBAMATE COMPOUNDS | 2015 |
|
RU2688673C2 |
Authors
Dates
2007-06-10—Published
2002-08-14—Filed